EFFICACY AND TOXICITY OBSERVED IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED IN PHASE I TRIALS AT A SINGLE INSTITUTION

被引：0
|
作者：
Raphael, J. [1 ]
Hollebecque, A. [2 ]
Le Teuff, G. [3 ]
Massard, C. [2 ]
Bahleda, R. [2 ]
Margery, J. [4 ]
Besse, B. [1 ]
Soria, J. [1 ]
Planchard, D. [1 ]
机构：
[1] Inst Gustave Roussy, INSERM, Thorac Grp, U981, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Gustave Roussy, Dept Stat & Epidemiol, Villejuif, France
[4] Percy Hosp, Dept Pulm, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [41] Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
    Ceresoli, G. L.
    Castagneto, B.
    Zucali, P. A.
    Favaretto, A.
    Mencoboni, M.
    Grossi, F.
    Cortinovis, D.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Salamina, S.
    De Vincenzo, F.
    Cappuzzo, F.
    Marangolo, M.
    Torri, V.
    Santoro, A.
    BRITISH JOURNAL OF CANCER, 2008, 99 (01) : 51 - 56
  • [42] Single-Agent Pembrolizumab for Patients with Malignant Pleural Mesothelioma (MPM)
    Alley, Evan W.
    Schellens, Jan H. M.
    Santoro, Armando
    Beckey, Kim
    Yuan, Shuai Sammy
    Cheng, Jonathan
    Piperdi, Bilal
    Molife, L. Rhoda
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [43] Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
    G L Ceresoli
    B Castagneto
    P A Zucali
    A Favaretto
    M Mencoboni
    F Grossi
    D Cortinovis
    G Del Conte
    A Ceribelli
    A Bearz
    S Salamina
    F De Vincenzo
    F Cappuzzo
    M Marangolo
    V Torri
    A Santoro
    British Journal of Cancer, 2008, 99 : 51 - 56
  • [44] A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma
    van Meerbeeck, JP
    Baas, P
    Debruyne, C
    Smit, EF
    van Klaveren, RJ
    Galdermans, D
    Lentz, MA
    Manegold, C
    Giaccone, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (06) : 779 - 783
  • [45] A phase II trial of gefitinib in patients with malignant pleural mesothelioma (MPM)
    Lee, C. W.
    Anderson, H.
    Martins, H.
    Rao, S. C.
    Sauciuc, D.
    Laurie, S. A.
    Morzycki, W.
    MacNeil, M. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma A Single Institution Study
    Tourkantonis, Ioannis
    Makrilia, Nektaria
    Ralli, Maria
    Alamara, Christina
    Nikolaidis, Ilias
    Tsimpoukis, Sotirios
    Charpidou, Andriani
    Kotanidou, Anastasia
    Syrigos, Kostas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 38 - 42
  • [47] Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study
    Berneman, Zwi N.
    Germonpre, Paul
    Huizing, Manon Thirza
    Van de Velde, Ann
    Nijs, Griet
    Stein, Barbara
    Van Tendeloo, Viggo F.
    Lion, Eva
    Smits, Evelien L.
    Anguille, Sebastien
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Chemonaive Patients With Unresectable Malignant Pleural Mesothelioma
    Tsao, Anne S.
    Harun, Nusrat
    Lee, J. Jack
    Heymach, John
    Pisters, Katherine
    Hong, Waun Ki
    Fujimoto, Junya
    Wistuba, Ignacio
    CLINICAL LUNG CANCER, 2014, 15 (03) : 197 - 201
  • [49] Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated with immune-oncology drugs (IO) in clinical trials
    Cedres, S.
    Martinez Marti, A.
    Navarro, A.
    Pardo, N.
    Remon, J.
    Matos, I.
    Ochoa de Olza, M.
    Hierro, C.
    Martin Liberal, J.
    Miquel, J. M.
    Viaplana, C.
    Villacampa Javierre, G.
    Dienstmann, R.
    Felip Font, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM)
    De Vincenzo, F.
    Rossoni, G.
    Santoro, A.
    Gregorc, V.
    Zucali, P. A.
    Citterio, G.
    Simonelli, M.
    Petrella, G.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345